The Supreme Court is deliberating the Affordable Care Act's mandate for insurers to cover preventive services at no cost. This decision could affect 150 million Americans' access to vital health services.
Today, the U.S. Supreme Court hears a pivotal case on Obamacare's preventive care mandate, with major implications for health coverage, including HIV prevention drugs like PrEP. Conservative employers argue the mandate is unconstitutional, raising fears about the future of essential health services.
The CDC's vaccine advisory committee met under new leadership, discussing potential changes in vaccination recommendations, especially for COVID-19, amid ongoing concerns about public health.
A recent measles outbreak in Texas highlights the consequences of underfunded immunization programs. With cuts to vaccine funding and rising vaccine hesitancy, health officials warn of a worsening public health crisis.
In a stunning move, Dr. Peter Marks resigns from the FDA, criticizing health leadership for allowing misinformation to guide vaccination safety policies. His departure highlights ongoing concerns about public health integrity.
Peter Marks, the FDA's Center for Biologics Evaluation and Research head, resigns amid growing concerns over measles outbreaks and vaccine misinformation. His exit raises alarms about future public health initiatives.
In a bold move, the U.S. Department of Health and Human Services is restructuring to save $1.8 billion annually while tackling America's chronic illness epidemic. With a workforce reduction and consolidation of divisions, the new plan promises efficiency and better health outcomes.
In a surprising turn, the Trump administration has terminated key funding for HIV programs aimed at adolescents, raising concerns over the future of HIV prevention efforts in the U.S.
In a bold move, Secretary Kennedy has ordered the removal of a controversial health website as the CDC plans a study linking vaccines to autism, amidst a growing measles outbreak impacting children across the nation.
In a surprising turn, the Trump administration is contemplating cuts to H.I.V. prevention efforts that previously saw significant success. What does this mean for public health?
